Marine natural products as anticancer agents 2.0

Detalhes bibliográficos
Autor(a) principal: Alves, Celso
Data de Publicação: 2023
Outros Autores: Diederich, Marc
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.8/8758
Resumo: [Introduction] Global cancer incidence and death are expected to increase to 28.4 million cases by 2040, despite efforts to understand cancer biology better and to improve its diagnosis and therapy [1]. Inappropriate therapeutic regimens and tumor recurrence due to the development of drug resistance are two major clinical challenges impacting poor patient outcomes [2]. Over the last few decades, the marine environment has become an important source of molecules with potent anticancer properties, exhibiting unusual chemical features and mechanisms of action. Twelve of seventeen drugs of marine origin approved by regulatory entities are used against cancer, and thirty-four of forty compounds in the marine pharmaceuticals pipeline indicate “cancer therapy” [3].
id RCAP_61471f6fdb463383942c20e018ad32a7
oai_identifier_str oai:iconline.ipleiria.pt:10400.8/8758
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Marine natural products as anticancer agents 2.0Marine natural productsAnticancer agentsSemi-synthesisMetastasisImmunotherapyMechanism of action[Introduction] Global cancer incidence and death are expected to increase to 28.4 million cases by 2040, despite efforts to understand cancer biology better and to improve its diagnosis and therapy [1]. Inappropriate therapeutic regimens and tumor recurrence due to the development of drug resistance are two major clinical challenges impacting poor patient outcomes [2]. Over the last few decades, the marine environment has become an important source of molecules with potent anticancer properties, exhibiting unusual chemical features and mechanisms of action. Twelve of seventeen drugs of marine origin approved by regulatory entities are used against cancer, and thirty-four of forty compounds in the marine pharmaceuticals pipeline indicate “cancer therapy” [3].Marc Diederich was supported by the National Research Foundation (NRF) by the MEST of Korea for Tumor Microenvironment Global Core Research Center (GCRC) grant (grant number NRF 2011-0030001), by the Seoul National University Research Grant (Funding number: 800-20160150) and by the Creative-Pioneering Researchers Program through Seoul National University (SNU) (Funding number: 370C-20160062). Research at SNU is also supported by the National Research Foundation (NRF) (Grant Number 2022R1A2C101314111). Support from the BrainKorea21 FOUR program is acknowledged. Marc Diederich is supported by the “Recherche Cancer et Sang” foundation, the “Recherches Scientifiques Luxembourg” association, the “Een Häerz fir kriibskrank Kanner” association, the Action LIONS “Vaincre le Cancer” association, and Télévie Luxembourg. C.A. acknowledges the support by the Portuguese Foundation for Science and Technology (FCT) through the Strategic Projects granted to MARE—Marine and Environmental Sciences Centre (UIDP/04292/2020 and UIDB/04292/2020), Associate Laboratory ARNET (LA/P/0069/2020), and through the NEURONS4 (2022.09196.PTDC), MArTics (FCT/DRI/CAPES 2019.00277.CBM) and NEURONS (FCT/DRI/PNAAE 2021.09608.CBM) projects.MDPIIC-OnlineAlves, CelsoDiederich, Marc2023-09-05T11:19:14Z20232023-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.8/8758engAlves, C.; Diederich, M. Marine Natural Products as Anticancer Agents 2.0. Mar. Drugs 2023, 21, 247. https://doi.org/10.3390/md210402471660-339710.3390/md21040247info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-01-17T15:58:06Zoai:iconline.ipleiria.pt:10400.8/8758Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:51:24.876788Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Marine natural products as anticancer agents 2.0
title Marine natural products as anticancer agents 2.0
spellingShingle Marine natural products as anticancer agents 2.0
Alves, Celso
Marine natural products
Anticancer agents
Semi-synthesis
Metastasis
Immunotherapy
Mechanism of action
title_short Marine natural products as anticancer agents 2.0
title_full Marine natural products as anticancer agents 2.0
title_fullStr Marine natural products as anticancer agents 2.0
title_full_unstemmed Marine natural products as anticancer agents 2.0
title_sort Marine natural products as anticancer agents 2.0
author Alves, Celso
author_facet Alves, Celso
Diederich, Marc
author_role author
author2 Diederich, Marc
author2_role author
dc.contributor.none.fl_str_mv IC-Online
dc.contributor.author.fl_str_mv Alves, Celso
Diederich, Marc
dc.subject.por.fl_str_mv Marine natural products
Anticancer agents
Semi-synthesis
Metastasis
Immunotherapy
Mechanism of action
topic Marine natural products
Anticancer agents
Semi-synthesis
Metastasis
Immunotherapy
Mechanism of action
description [Introduction] Global cancer incidence and death are expected to increase to 28.4 million cases by 2040, despite efforts to understand cancer biology better and to improve its diagnosis and therapy [1]. Inappropriate therapeutic regimens and tumor recurrence due to the development of drug resistance are two major clinical challenges impacting poor patient outcomes [2]. Over the last few decades, the marine environment has become an important source of molecules with potent anticancer properties, exhibiting unusual chemical features and mechanisms of action. Twelve of seventeen drugs of marine origin approved by regulatory entities are used against cancer, and thirty-four of forty compounds in the marine pharmaceuticals pipeline indicate “cancer therapy” [3].
publishDate 2023
dc.date.none.fl_str_mv 2023-09-05T11:19:14Z
2023
2023-01-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.8/8758
url http://hdl.handle.net/10400.8/8758
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Alves, C.; Diederich, M. Marine Natural Products as Anticancer Agents 2.0. Mar. Drugs 2023, 21, 247. https://doi.org/10.3390/md21040247
1660-3397
10.3390/md21040247
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv MDPI
publisher.none.fl_str_mv MDPI
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137005740752896